Prescribers’ Clinical Support System for Opioid Therapies (PCSS-O) is a three year grant funded by Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT). It is a collaborative project led by American Academy of Addiction Psychiatry (AAAP) with: American Dental Association (ADA), American Medical Association (AMA), American Osteopathic Academy of Addiction Medicine (AOAAM), American Psychiatric Association (APA), American Society for Pain Management Nursing (ASPMN), and International Nurses Society on Addictions (IntNSA). These organizations are providing training and education on the safe and effective prescribing of opioid medications in the treatment of pain and/or opioid addiction.
Office-based Treatment of Opioid Dependence with Buprenorphine
By David A. Fiellin, M.D Professor of Medicine, Investigative Medicine and Public Health Yale University School of Medicine
Module Description: This online module describes the legislation and basic components of office-based treatment of opioid dependence with buprenorphine. Buprenorphine is a partial agonist opioid that is approved for the treatment of heroin and prescription opioid dependence. The module outlines how through appropriate patient assessment and resource matching, evidence suggests that many, but not all, opioid dependent patients can achieve good treatment outcomes through office-based treatment with buprenorphine.
Funding for this initiative was made possible (in part) by Prescribers’ Clinical Support System for Opioid Therapies (1H79TI023439) from SAMHSA.The views expressed in written conference materials or publications andby speakers and moderators do not necessarily reﬂect the ofﬁcialpolicies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.